Immunotherapeutic strategies in non-small-cell lung cancer: the present and the future.

about

A Predictive 7-Gene Assay and Prognostic Protein Biomarkers for Non-small Cell Lung Cancer.

P2860

Q55398332-2B18F2E1-206C-428C-825E-7DB52782241A

P2860

Immunotherapeutic strategies in non-small-cell lung cancer: the present and the future.

Item

http://www.wikidata.org/entity/Q38687631

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Immunotherapeutic strategies in non-small-cell lung cancer: the present and the future.

@en

type

Item

label

Immunotherapeutic strategies in non-small-cell lung cancer: the present and the future.

@en

prefLabel

Immunotherapeutic strategies in non-small-cell lung cancer: the present and the future.

@en

P1476

Immunotherapeutic strategies in non-small-cell lung cancer: the present and the future.

@en

P2093

Christi M Steendam

http://www.w3.org/2001/XMLSchema#string

Floris Dammeijer

http://www.w3.org/2001/XMLSchema#string

Joachim G J V Aerts

http://www.w3.org/2001/XMLSchema#string

Robin Cornelissen

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Hallmarks of Cancer: The Next Generation

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?

CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients.

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.

Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports

Cancer immunotherapy via dendritic cells

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

P304

507-520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT-2016-0151

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28472903

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

Immunotherapeutic strategies in non-small-cell lung cancer: the present and the future.

about

P2860

P2860

Immunotherapeutic strategies in non-small-cell lung cancer: the present and the future.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921